Pregabalin + Placebo for pregabalin
Pre-clinicalTerminated 0 views this week 0 watching💤 Quiet
Interest: 18/100
18
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Spinal Cord Injuries
Conditions
Spinal Cord Injuries
Trial Timeline
Feb 1, 2007 → Oct 1, 2008
NCT ID
NCT00978341About Pregabalin + Placebo for pregabalin
Pregabalin + Placebo for pregabalin is a pre-clinical stage product being developed by Pfizer for Spinal Cord Injuries. The current trial status is terminated. This product is registered under clinical trial identifier NCT00978341. Target conditions include Spinal Cord Injuries.
What happened to similar drugs?
7 of 20 similar drugs in Spinal Cord Injuries were approved
Approved (7) Terminated (1) Active (12)
Hype Score Breakdown
Clinical
3
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00978341 | Pre-clinical | Terminated |
Competing Products
20 competing products in Spinal Cord Injuries